Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.22 -0.08 (-6.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alx Oncology Holdings (ALXO) Return on Equity [ROE] (2020 - 2026)

Updated

Alx Oncology Holdings (ALXO) posted Return on Equity [ROE] of -55.57% for Q2 2026, up 97.09 percentage points from -152.66% a year earlier and up 44.84 percentage points from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Alx Oncology Holdings' Return on Equity [ROE] came in at -145.70%, down 56.78 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -120.23 percentage points (FY2020 to FY2025).
  • In prior years, Alx Oncology Holdings' Return on Equity [ROE] was -88.91% in FY2024 (-17.95 pp), -70.97% in FY2023 (-31.55 pp), -39.42% in FY2022 (-18.37 pp) and -21.05% in FY2021 (+4.41 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q1 2023.
  • On a year-over-year basis, Return on Equity [ROE] increased in two of the last eight quarters, with an average year-over-year change of -34.28 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2026, with a gain of 97.09 percentage points; the weakest was Q4 2025, with a drop of 179.57 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -100.41% (Q1 2026), -287.25% (Q4 2025) and -197.76% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Alx Oncology Holdings 168.62 Mn 168.62 Mn - -55.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -55.57%
Mar 31, 2026 -100.41%
Dec 31, 2025 -287.25%
Sep 30, 2025 -197.76%
Jun 30, 2025 -152.66%
Mar 31, 2025 -128.77%
Dec 31, 2024 -107.68%
Sep 30, 2024 -102.06%
Jun 30, 2024 -105.96%
Mar 31, 2024 -94.08%
Dec 31, 2023 -89.94%
Sep 30, 2023 -76.76%
Jun 30, 2023 -57.70%
Mar 31, 2023 -51.27%
Dec 31, 2022 -44.84%
Sep 30, 2022 -40.19%
Jun 30, 2022 -33.48%
Mar 31, 2022 -26.56%
Dec 31, 2021 -22.32%
Sep 30, 2021 -18.68%
API Access

Alx Oncology Holdings Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALXO&period=max&api_key=YOUR_API_KEY